Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Paradoxical roles of the immune system during cancer development.
de Visser KE, Eichten A, Coussens LM. de Visser KE, et al. Among authors: eichten a. Nat Rev Cancer. 2006 Jan;6(1):24-37. doi: 10.1038/nrc1782. Nat Rev Cancer. 2006. PMID: 16397525 Review.
Analysis of immune cell infiltrates during squamous carcinoma development.
Junankar SR, Eichten A, Kramer A, de Visser KE, Coussens LM. Junankar SR, et al. Among authors: eichten a. J Investig Dermatol Symp Proc. 2006 Sep;11(1):36-43. doi: 10.1038/sj.jidsymp.5650024. J Investig Dermatol Symp Proc. 2006. PMID: 17069009 Free article.
Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.
Zhao Q, Eichten A, Parveen A, Adler C, Huang Y, Wang W, Ding Y, Adler A, Nevins T, Ni M, Wei Y, Thurston G. Zhao Q, et al. Among authors: eichten a. Cancer Res. 2018 May 1;78(9):2370-2382. doi: 10.1158/0008-5472.CAN-17-2728. Epub 2018 Feb 15. Cancer Res. 2018. PMID: 29449267 Free article.
Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH, Minchinton AI, Yancopoulos GD, Thurston G. Daly C, et al. Among authors: eichten a. Cancer Res. 2013 Jan 1;73(1):108-18. doi: 10.1158/0008-5472.CAN-12-2064. Epub 2012 Nov 13. Cancer Res. 2013. PMID: 23149917 Free article.
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.
Egeblad M, Shen HC, Behonick DJ, Wilmes L, Eichten A, Korets LV, Kheradmand F, Werb Z, Coussens LM. Egeblad M, et al. Among authors: eichten a. Dev Dyn. 2007 Jun;236(6):1683-93. doi: 10.1002/dvdy.21159. Dev Dyn. 2007. PMID: 17440987 Free PMC article.
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade.
Eichten A, Su J, Adler AP, Zhang L, Ioffe E, Parveen AA, Yancopoulos GD, Rudge J, Lowy I, Lin HC, MacDonald D, Daly C, Duan X, Thurston G. Eichten A, et al. Cancer Res. 2016 Apr 15;76(8):2327-39. doi: 10.1158/0008-5472.CAN-15-1443. Epub 2016 Feb 26. Cancer Res. 2016. PMID: 26921327 Free article.
Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models.
Eichten A, Adler AP, Cooper B, Griffith J, Wei Y, Yancopoulos GD, Lin HC, Thurston G. Eichten A, et al. Angiogenesis. 2013 Apr;16(2):429-41. doi: 10.1007/s10456-012-9328-3. Epub 2012 Dec 13. Angiogenesis. 2013. PMID: 23238831 Free PMC article.
15 results
Jump to page